通过蛋白激酶B酸化在结肠直肠癌中对EEPD1的致癌作用
Ruiya Ma1, Tadanobu Shimura2, Chengzeng Yin2
1Department of Gastrointestinal and Pediatric Surgery, Institute of Life Sciences, Mie University Graduate School of Medicine, Tsu, Mie, Japan; Department of Surgery, Tangshan Gongren Hospital, Tangshan, China.
内核酶/外核酶/酸酶家族域含有1 (EEPD1) 在结直肠癌 (CRC) 中升高,并与较差的存活率有关. 针对EEPD1可能为CRC患者提供新的治疗策略.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 遗传学 遗传学是一种遗传学.
背景情况:
- 内核酶/外核酶/酸酶家族含域1 (EEPD1) 在DNA修复中起作用,特别是在氧化应激复制叉中.
- 在结直肠癌 (CRC) 病原发生过程中,EEPD1的功能在很大程度上仍未被探索.
研究的目的:
- 调查EEPD1在结直肠癌中的瘤学意义.
- 评估EEPD1作为CRC的潜在预后和预测生物标志物.
主要方法:
- 在289个CRC患者样本中使用RT-qPCR和免疫组织化学量化EEPD1mRNA和蛋白质水平.
- 通过测量增殖,迁移,亡和AKT信号的体外试验,评估了EEPD1在CRC细胞系 (SW620,WiDr) 中的功能作用.
主要成果:
- 与相邻的正常粘膜相比,EEPD1表达在CRC瘤组织中显著上调.
- 高EEPD1水平与CRC患者的总生存率和无复发生存率显著降低相关.
- 降低EEPD1抑制了增殖和迁移,诱导了亡,并减少了CRC细胞中的AKT酸化.
结论:
- EEPD1是结直肠癌的宝贵预后和复发预测生物标志物.
- EEPD1代表了结直肠癌治疗的潜在治疗标.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
12:26Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
相关概念视频
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
Mitogens and the Cell Cycle
Abnormal Proliferation
